Epstein-barr Virus Infection
📧 Sign up to get email alerts when something new happens for Epstein-barr Virus Infection.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2024-11-14Clinical Trial Update: Investigating Epstein-Barr Virus Associated Conjunctivitis
A Moorfields Eye Hospital clinical trial is enrolling participants to study Epstein-Barr virus-associated conjunctivitis.
-
CLINICAL_TRIALS research · 2024-10-30Clinical Trial Update: Study to Evaluate the Efficacy of 2LEBV® and 2LXFS® on Asthenia in Patients With an Epstein-Barr Virus Infection [Phase 4]
A Phase 4 trial to evaluate the efficacy of two products, 2LEBV and 2LXFS, on asthenia in patients with Epstein-Barr virus infection, curren…
-
CLINICAL_TRIALS research · 2024-08-28Clinical Trial Update: Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis [Phase 1, Phase 2]
The document describes a Phase 1/2 clinical trial evaluating adoptive cord blood immunotherapy to prevent or treat reactivation/infection wi…
-
CLINICAL_TRIALS research · 2024-08-15Clinical Trial Update: Evaluation of CMV/EBV-CMI in Haploid HSCT
A study evaluating CMV/EBV-specific cellular immune responses in haploid hematopoietic stem cell transplantation is currently recruiting.
-
CLINICAL_TRIALS research · 2017-07-02Clinical Trial Update: Protein Studies of the Epstein-Barr Virus in Ethnically Diverse Populations
The NIH-sponsored clinical trial examining Epstein-Barr virus protein studies across ethnically diverse populations has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2016-07-21Clinical Trial Update: Partially HLA-matched Third Party Antigen Specific T-cells for Infection Post-stem Cell or Solid Organ Transplantation [Phase 1]
Phase 1 clinical trial evaluating partially HLA-matched third-party antigen-specific T-cells for preventing or treating CMV, EBV, and adenov…
-
CLINICAL_TRIALS research · 2016-02-22Clinical Trial Update: Administration of Virus Specific CTLs for the Prophylaxis and Treatment of EBV/CMV Infections After HSCT in China [Phase 1]
This is a Phase 1 clinical trial in China evaluating virus-specific cytotoxic T lymphocytes to prophylactically prevent and therapeutically …
-
CLINICAL_TRIALS research · 2011-12-22Clinical Trial Update: Modified Vaccinia Ankara (MVA) Vaccine Study [Phase 1]
A Phase 1 study of a Modified Vaccinia Ankara (MVA) vaccine for nasopharyngeal carcinoma and Epstein-Barr virus infection has completed.
-
CLINICAL_TRIALS research · 2010-11-25Clinical Trial Update: The Prevelance Rate of Human Cytomegalovirus (HCMV), Epstein-Barr Virus (EBV) and Human Herpes Virus (HHV-6) in a Saliva of the Patient With Periodantitis
Clinical trial update examining the prevalence of cytomegalovirus, Epstein-Barr virus, and HHV-6 in the saliva of a patient with periodontit…